We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ohio Attorney General Dave Yost has asked the Sixth Circuit Court of Appeals to delay an upcoming trial of two bellwether cases brought by Cuyahoga and Summit counties against Purdue Pharma. Read More
In a win for Allergan, the U.S. Court of Appeals for the Federal Circuit upheld a federal court ruling blocking Sandoz’s proposed generic of Allergan’s eye drops Combigan (brimodine/timolol). Read More
The Patent Trial and Appeal Board (PTAB) said it’s opening an inter partes review (IPR) of patents covering Alexion Pharmaceuticals’ immunosuppressive drug Soliris (eculizumab), following a petition by Amgen. Read More
PhRMA said it “strongly encourages” the FDA’s new “integrated review process,” which combines assessments by the agency’s different disciplines into a single document for new drug applications and efficacy supplements. Read More